FOLH1 and Familial prostate cancer: Schwarzenboeck et al. [34] (Rostock, Germany) analysed the use of 68Ga-PSMA PET/CT in 38 patients with prostate cancer with a high risk or persistence or biochemical recurrence who were candidates for radiation therapy.